
Drug Development Journey
From a hunch about biology to a medicine on the shelf

Six lightweight games and tools: follow a drug from lab to approval, reality-check a headline, build a cell, decode a genome, explore an MRI and test your vocabulary. Educational only — no diagnoses, risk estimates or stock tips.

From a hunch about biology to a medicine on the shelf

Five questions to ask before you share a headline


Why a variant rarely gives a simple prediction


Four quick decks. Replayable. Shareable scores.

An animated primer on what separates a cancer cell from a normal one, from uncontrolled division to evading the body's usual checks. Viewers also…

A short National Cancer Institute explainer on CAR T-cell therapy, in which a patient's own T cells are engineered to recognize and attack cancer.…

Explains how tumors exploit immune 'checkpoints' to switch off T cells and how checkpoint-blocking drugs release those brakes. A useful foundation for understanding much…

CRISPR co-inventor Jennifer Doudna describes how a bacterial immune system became a programmable tool for editing DNA. She also raises the ethical questions that…

An animated overview of how genetic engineering developed and why CRISPR made editing DNA cheaper and more precise. It walks through potential medical uses…

A plain-language look at the physics behind magnetic resonance imaging, from powerful magnets to radio pulses and hydrogen atoms in the body. Viewers come…
One concise weekly roundup of what moved in medicine — what happened, what the evidence shows, and what to watch next. No hype, no stock tips.
We use double opt-in: check your inbox to confirm. We never sell your address, and we never ask for health or genetic information.